Voglibose is an oral anti-diabetic API (active pharmaceutical ingredient) belonging to the alpha-glucosidase inhibitor class. It acts locally in the small intestine by competitively inhibiting enzymes (alpha-glucosidases) responsible for breaking down complex carbohydrates into monosaccharides. This delays and reduces postprandial (after-meal) gluc